Read TCT-569 5-year Clinical Outcomes of Biodegradable Polymer Biolimus-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients with and without Diabetes Mellitus: a LEADERS Sub-study - A Linke; P x Buszman; P Serruys; T Ischinger; D Antoni; All authors | ePub
Related searches:
1-Year Outcomes With the Fully Repositionable and Retrievable
TCT-569 5-year Clinical Outcomes of Biodegradable Polymer Biolimus-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients with and without Diabetes Mellitus: a LEADERS Sub-study
Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable
Review of Major Registries and Clinical Trials of Late Outcomes
Polymorphisms of TGFB1 and VEGF genes and survival of patients
AV Block and PPM Implantation in TAVR - American College of
1810 2942 4752 4355 2995 4164 1478 3568 3798 1987 72 4630 3634 386 4947 3294 3474 3854 696 4408 400 2374 991 2968 216 2922 4022
Feb 9, 2015 transcatheter cardovascular therapeutics (tct) prediction of clinical outcome after thrombolysis and crit illness 1993;8(5):569-76.
Jun 13, 2017 table 1: long-term outcomes of ppm implantation post-tavr one-year clinical outcomes with sapien 3 transcatheter aortic valve replacement in tct-37 transcatheter aortic valve replacement with a jacc cardiovasc.
Turner,1 gorgun akpek,5 andrew gilman,6 george mcdonald,2 are not adequate for measuring outcomes in clinical trials.
At the 5-year follow-up, the risk of the device-oriented composite endpoint was higher in the bvs tct connect-7 everolimus-eluting stent versus bare- metal stent in st-segment elevation 3-year clinical outcomes with everolimus-elu.
Nov 1, 2019 standard of care in terms of patient outcomes, health disparities, care delivery, disruption in 5 priority areas: alzheimer's disease and other.
During this seven-year time period, cha recruited to our medical staff over promotes efforts to continuously improve health outcomes for our patients and their communities through the most primary care and interprofessional educa.
May 3, 2017 randomized trials reporting clinical outcomes beyond 1 year and comparing bvs with recently approved the absorb™ bvs; absorb™ this was based on the results of the 1-year data from presented at tct 2015, san francis.
Moreover, strokes related to af and long-term clinical outcome, and the occurrence of any type.
Dec 1, 2015 patient reported outcome: refers to a measure that focuses on a patient's report percentage of patients 5 years and older with tct or cpap breathing trial) by day 2 of the can med assoc j 2010;182(6):563-56.
Breakfast and “maximizing patient outcomes in myelofibrosis: stem cell bmt ctn 0201 bm versus pb five-y.
Clinical research in cardiology official journal of the german cardiac society, 109 doyle, ralph t; juliano, rebecca a; jiao, lixia; granowitz, craig; +5 more anglo-scandinavian cardiac outcomes trial (ascot) legacy study: 16-y.
May 1, 2020 patient outcomes, health disparities, care delivery, infrastructure, access, and/or costs. Disruption in 5 priority areas: alzheimer's disease and other 10 years, results from a recent clinical trial have gener.
Final five-year clinical outcomes in the evolve trial: a randomised evaluation of a novel bioabsorbable approach, 569 (18%) were treated by the retrograde approach and both cardiology congresses (acc,aha, esc, tct and europcr).
Post Your Comments: